aXichem AB (FRA:A6X)
0.1710
-0.0005 (-0.29%)
At close: Nov 28, 2025
aXichem AB Company Description
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden.
It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets.
The company was founded in 1999 and is based in Malmö, Sweden.
aXichem AB
| Country | Sweden |
| Founded | 1999 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 7 |
| CEO | Torsten Helsing |
Contact Details
Address: SOedergatan 26 Malmö, 211 34 Sweden | |
| Phone | 46 4 67 80 06 73 |
| Website | axichem.com |
Stock Details
| Ticker Symbol | A6X |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Torsten Helsing | Chief Executive Officer |
| Erik Lager | Chief Operating Officer |
| Gunilla Savring | Head of Investor Relations |